Mirati Therapeutics, Inc.
Overview
Mirati Therapeutics, Inc. is a clinical-stage biotechnology company that develops targeted therapies to treat cancer. The company focuses on genetic and epigenetic drivers of cancer and leverages precision medicine strategies to address the unmet medical needs of cancer patients.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Mirati Therapeutics, Inc. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Mirati Therapeutics, Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.